"Nanobrid" is privately held company offering proprietary next generation lipid-polymer hybrid nanotechnology platform


Redefine patient experience and clinical outcomes through next generation formulation science

Our team

Dr. Deepak Chitkara

Deepak is a formulation scientist trained in India and USA and is currently Assistant Professor at the Department of Pharmacy, Birla institute of Technology and Science (BITS). Deepak holds a Ph.D. and specializes in the development of nanotechnology-based drug delivery platforms. Deepak is focusing on advancing research programs across range of molecules / drug delivery platforms and scaling-up R&D capabilities.

Nemisha Patel

An astute pharmaceutical professional with 22 plus years of exceptional expertise in the pharmaceutical/ medical device industries. Nemisha has 17 years of experiences in development of pre-clinical platforms of novel vaccines, biologics and diagnostics at Merck Pharmaceuticals and B.Braun Medical Inc. Nemisha is a respected professional in the industry, recommended by the industry for consultation on areas of Regulatory Compliance and Quality Assurance. Nemisha holds a M.S. in Microbiology from Thomas Jefferson University and B.S. in Biology from Temple University.

Mayank Bhanderi

Mayank has 13+ years of experience in multi-national consulting and pharmaceutical companies. Mayank has expertise in the areas of health economics and outcome research, medical affairs, operations, developing strategy and managing innovation. Mayank holds Masters in Pharmacy from National Institute of Pharmaceutical Education & Research (NIPER), Chandigarh, India and completed Advance Management Program from Indian Institute of Management (IIM), Bangalore, India.

Dr. Anupama Mittal

Anupama holds a Ph.D. degree in pharmaceutical sciences from India and did her post-doctoral training in the United States before joining as a faculty at the Department of Pharmacy, Birla Institute of Technology and Science-Pilani (BITS-Pilani). She specializes in the development of new formulations for difficult to deliver molecules using nanotechnology-based approaches.

Our extended team

We are proud of broad network of specialists in the areas of formulation science, intellectual property rights, regulatory affairs, pharmaceutical industry veterans, and researching clinicians.